Back

Transthyretin cardiac amyloidosis in heart failure with preserved ejection fraction: Imaging by Tc-99m bone scan

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Inflammatory and infiltrative cardiomyopathy Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Shigeru Fukuzawa

Funabashi Municipal Medical Center, Funabashi (Japan)

9 More presentations in this session

Presentation thumbnail
Diagnosis of transthyretin versus light chain cardiac amyloidosis by apical sparing strain ratio in patients with clinically suspected disease
Professor J. Gorcsan (St Louis, US)
Abstract Slides
Presentation thumbnail
Extremely boosted prediction of cardiac amyloidosis by routine laboratory paramaters
Doctor A. Agibetov (Vienna, AT)
Abstract Slides
Presentation thumbnail
Hemodynamic profiles in patients with cardiac amyloidosis
Doctor F. Duca (Vienna, AT)
Abstract
Presentation thumbnail
Prognostic impact of left atrial function in patients with cardiac amyloidosis: a cardiac magnetic resonance study
Doctor F. Cappelli (Florence, IT)
Abstract Slides
Presentation thumbnail
NT-proBNP and high-sensitivity cardiac troponin T to diagnose cardiac amyloidosis
Doctor V. Castiglione (Pisa, IT)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 3 - Inflammatory and infiltrative cardiomyopathy

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Pharmacotherapy in HFpEF: where do cardiometabolic drugs fit in?
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources